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This article reports measurements of household levels of gamma and cosmic rays at the addresses of children with cancer at
the time of diagnosis and six months before, and of similar data at the addresses of control children. There is no indication of
increased risk with increasing dose rates either in matched or unmatched analyses, with or without adjustment for deprivation.
Sub-division by diagnostic group did not reveal any association with any speciﬁc types of malignancy. Studies of the relationship
between household gamma rays and radon concentration show no evidence of any interactions.
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The United Kingdom Childhood Cancer Study had, as one of its
a priori hypotheses, that ionising radiation from natural sources
within households might cause childhood cancer. To address this
question separate household measurements were made of radon
gas concentration and of penetrating external radiation (predo-
minantly from terrestrial gamma rays and cosmic rays). Whilst
there was special interest in the biological effects of high linear
energy transfer (LET) irradiation from radon and its short term
decay products (UKCCS Investigators, 2002), there was little
reason to think that there would be detectable haematological
effects arising from differential exposures to domestic gamma
ray radiation. Risk estimates, based on standard radiological
protection approaches, have suggested that up to about 20% of
childhood and young adult leukaemias (aged 0–24) in the UK
could be due to natural low-LET radiation, including terrestrial
gamma rays (COMARE, 1996; Simmonds et al, 1995). However,
variation in gamma ray levels between households are likely to
be quite modest. There are few published studies of possible
childhood cancer risks from domestic gamma ray levels. One
correlation study has suggested that there may be a negative
trend in risk for childhood leukaemia associated with domestic
gamma levels (Muirhead et al, 1992). This trend was partially
reversed when administrative district data were analysed with
adjustment for counties. However, a subsequent study, which
also adjusted for area socio-economic status, showed no associa-
tion (Richardson et al, 1995).
There have been many studies of terrestrial and cosmic gamma
ray from many countries recording natural (and local) variation in
dose rate (UNSCEAR, 1993). The UK study of this type (Wrixon et
al, 1988), conducted by the National Radiological Protection Board
(NRPB) with data on over 2000 households from measurements
taken in the 1980’s, allows comparisons with the results of the
present study.
METHODS
The UKCCS was designed as a population-based matched case–
control study covering the whole of Great Britain. Ten regional
centres (Figure 1) administered the same study protocol, with
minor regional modiﬁcation to satisfy local ethical committee
approval and practical considerations. The study methods are given
in more detail elsewhere (UKCCS Investigators, 2000).
Study subjects
During the study period, all children with malignant neoplasms
aged under 15 years in England, Wales and Scotland were regis-
tered through liaison with oncologists and paediatricians. The
study began accruing cases in 1991 for Scotland and in 1992 for
England and Wales. Scotland terminated case registration at the
end of 1994. In England and Wales, registration of solid tumours
was terminated at the end of 1994, of non-Hodgkin’s lymphoma
in 1995, and of leukaemias in 1996. All neoplastic diagnoses were
submitted for central pathological review.
With few exceptions, each case had two randomly selected
controls, matched by sex, calendar month of birth and (former)
Family Health Services Authority (England and Wales) or Scottish
Health Board of residence. Children were eligible if they were born
in Great Britain, had no prior malignancy and were not in local
authority care. Subjects were ineligible if they themselves or their
parents had lived outside Great Britain for the three months lead-
ing up to diagnosis. Eligible controls who declined to participate
were replaced until two controls were enrolled (UKCCS Investiga-
tors, 2000).
Measurement of gamma radiation
A face-to-face interview was conducted with each child’s parents,
covering social, occupational and medical histories of the child
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www.bjcancer.comand parents. A full residential history for the child was also
collected and all addresses lived in by the child for 6 months or
more were targeted for measurement. A written request to partici-
pate was then made to each residence. Following agreement, two
radon and two thermoluminescent dosimeters (TLD) or ‘gamma’
detectors were sent to each household with instructions to place
one of each in the main bedroom and in the main living area. After
6 months had elapsed a letter was sent recalling the detectors,
which were returned to the NRPB for processing and measurement
of the cumulative exposure. This study reports on the results of the
address of the case at diagnosis, that is, those who had lived at that
address for at least the previous 6 months.
The system used for passive environmental photon monitoring
consisted of a modiﬁcation of a standard body TLD used for
personal photon monitoring and the assessment of dose is based
on two 30% LiF;Mg;Ti detector elements. These detectors respond
to all types of penetrating ionising radiation including terrestrial
gamma rays and secondary particles resulting from cosmic rays.
The results are expressed as absorbed dose to air. Annual esti-
mates are in micro gray (mGy) per year and hourly dose rates in
nano gray (nGy) per hour. The results given in this study include
the dose from cosmic rays; this varies with height above sea level,
but differences within the UK are small. The mean has been esti-
mated to be 32 nGy per hour (UNSCEAR, 2000) or 280 mGy per
year.
The main problems encountered with the detectors were occa-
sional damaged detectors, faulty readouts, and differences
between the recorded doses on the two detectors of greater than
20%. In all these cases the result was excluded from the analysis.
It is estimated that this occurred for between 5 and 10% of
measurements. Where the readings of the two detectors differed
by less than 20%, the mean value was used. Doses accumulated
away from the household of measurement were allowed for by
subtracting 2.3 mGy for each day in storage, and 0.9 mGy for each
day in transit.
Detectors were intended to be in place for 6 months but the
period over which measurements were actually made varied. The
analyses were restricted to the measurements of the doses that
had accumulated with the detectors in place within a household
for both living-room and bedroom for between 5 and 7 months.
Over 99% of all detectors met this requirement.
Deprivation scores
An area-based index of deprivation for the child’s residence at the
time of diagnosis, and 6 months before, based on an index used in
a previous study of childhood leukaemia (Draper et al, 1991), was
used to provide a proxy socio-economic adjustment (UKCCS,
2000). The index was calculated for the smallest 1991 census area,
that is an enumeration district (ED) in England and Wales or an
output area (OA) in Scotland. Proportions of the following vari-
ables within each ED/OA were calculated: economically active
persons unemployed, households with no car, households not
owner-occupied, and overcrowded households (more than one
person per room). The variables were log-transformed (to reduce
skewness to zero), standardised (mean of zero and standard devia-
tion of one) and the standard deviates summed for each ED/OA.
The deprivation index was used to provide seven categories, with
equal numbers of ED/OA’s in each category. Greater values in
the deprivation index represent greater deprivation. All targeted
houses were given a validated postal code and allocated to an
ED or OA from the 1991 census.
Statistical analysis
All statistical analyses were performed using Stata version 6 (Stata
Corporation, 1998). All estimates of risk are presented as odds
ratios, derived using conditional logistic regression modelling. To
check that data for incomplete sets, dropped after matching, did
not unduly inﬂuence the results, all analyses were repeated with
logistic regression modelling, adjusted for age and sex (the match-
ing variables). The data were checked for confounding between
socio-economic status and household gamma.
RESULTS
The parents of 3838 children with cancer and 7629 children with-
out cancer were interviewed, representing 87% of eligible cases and
64% of eligible controls. Following interview, measurements were
obtained from the home at diagnosis of 2165 cases and 5086
controls. Nearly all (97%) estimates were based on readings
obtained from both the bedroom and the living room.
The case household participation for TLD ‘gamma’ detection
was virtually identical to that for radon measurements. Thus all
the issues that arose from the differential response rates of the case
and control families and from the overall response rates are similar
to those discussed in the accompanying radon paper (UKCCS,
2002). Table 1 gives details of what happened to the detectors after
they were sent to those households which agreed to participate.
The study accrued results from over 10000 households. Figure 2
shows the distribution of gamma rays results from the 5086 control
households, showing a mean annual absorbed dose of 843 mGy
with individual values varying from undetectable levels (i.e. under
100 mGy y
71) to a maximum of 2027 mGy y
71.
Table 2 gives the control measurements reported for nine
regions (two, Central and South Wales being combined) and for
the seven socio-economic groups. The mean household dose rates
vary throughout the country: the highest levels being in the North
East Region of England and Trent and the lowest in the South
West Region of England (See Figure 1). This is commented on
in the discussion. The mean dose rates vary with deprivation score,
the most deprived households having the highest mean dose rate.
Although there are trends in the dose rates by deprivation, and
there is also an apparent geographical variation, neither set of
results is statistically signiﬁcant due to the wide scatter of results
and the consequentially high standard deviations.
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Figure 1 Regions and study centres of the UKCCS. UKCCS study re-
gions: SC Scotland; NE North-east; NW North-west; TR Trent; CE Central;
EA East Anglia; SM South Midlands; SWA South-Wales; SW South-west;
SE South-east
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showed little variation over the period of the study (results not
shown). Table 3 shows the overall odds ratio (for any cancer)
and household dose rate based on quintiles, using both matched
and unmatched analyses. The results show no relationship between
either crude results or results adjusted for deprivation and
increased odds ratios for childhood cancer. Separate data from
six diagnostic groups are given in Table 4. There is no suggestion
of either an increasing or decreasing risk from any of the groups.
For CNS tumours, the odds ratios increase with increasing dose
rate only to a maximum of 33% and the trend is not statistically
signiﬁcant (P=0.15)
Radon – Gamma interaction
The relationships between TLD-derived doses divided into thirds
(under 758.1, 758.1–956.6, over 956.6) and radon concentra-
tions split into the ﬁve predeﬁned levels (see radon paper,
this issue) of 0–24, 25–49, 50–99, 100–199 and 200+
Bqm
73 is shown in Table 5. There is no suggestion of any
interactions, apart from a weak association at the highest
gamma and radon level, which is not statistically signiﬁcant.
When the analyses are conducted using quintiles of radon expo-
sure, no such association appears.
DISCUSSION
To our knowledge this is the ﬁrst case–control study directly
measuring domestic gamma ray and cosmic ray levels and relating
this to the risk of all childhood cancers. The results relate to the
households of the affected children at the time of diagnosis, and
are limited to children who had lived at the address for a mini-
mum period of 6 months, the control households having the
same limitations. The study is limited by accuracy of the TLD
measurements, including inherent detector variability, storage,
transport, householder compliance and the assumption of constant
cosmic ray dose rate irrespective of altitude of the household. Some
indication of combined uncertainties can be obtained from Figure
2. If it is assumed that the dose from cosmic rays is approximately
consistent at 34 nGy per hour, then this should produce a reading
on all detectors of about 300 mGy per year. The fact that there were
some TLD measurements in the below 300 mGy per year category
(see Figure 2) suggests that these measurements can carry uncer-
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Table 1 *TLD measurements for all houses where attempts were made to record measurements (household of the case at the time of diagnosis and its
equivalent control address)
Cases Controls Total
Detectors Houses Detectors Houses Detectors Houses
Total from interviewed subjects (%) 8059 (100)** 4002 (100) 12 542 (100) 6244 (100) 20 601 (100) 10 246 (100)
Exclusions
Detector faulty 1344 (17) 579 (14) 2311 (18) 1029 (16) 3655 (18) 1608 (15)
Address unknown 156 (2) 79 (2) 220 (2) 111 (2) 376 (2) 190 (2)
Ineligible person 8 (51) 4 (51) 4 (51) 2 (51) 12 (51) 6 (51)
No census information 7 (51) 4 (51) 8 (51) 4 (51) 15 (51) 8 (51)
Detectors placed 53 months 15 (51) 8 (51) 4 (51) 2 (51) 19 (51) 10 (51)
Fading too large 0 (0) 0 (0) 1 (51) 1 (51) 1 (51) 1 (51)
In transit 445 days 18 (51) 9 (51) 17 (51) 9 (51) 35 (51) 18 (51)
Measurement valid 6511 (81) 3319 (83) 9977 (80) 5086 (81) 16 488 (80) 8405 (82)
Both rooms 6384 (79) 3192 (80) 9762 (78) 4881 (78) 16 146 (78) 8073 (79)
Bedroom only 61 (1) 61 (2) 71 (1) 71 (1) 132 (1) 132 (1)
Living room only 66 (1) 66 (2) 134 (1) 134 (2) 200 (1) 200 (2)
*TLD=Thermoluminescent device. **Percentage of total from interviewed subjects in parenthesis.
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Figure 2 Frequency of absorbed dose rate in control houses.
Table 2 Summary of absorbed dose rates for controls by area and de-
privation scores
Annual
Mean Std Dev Min Max
Number (mGy y
71)( mGy y
71)( mGy g
71)( mGy g
71)
Total controls 5086 842.5 249.9 0 2027.2
Region
North-west 771 889.7 209.7 0 1470.5
North-east 651 975.9 234.3 53.0 1614.4
South-west 649 722.6 267.6 0 2027.2
Trent 487 967.1 218.5 64.5 1578.4
Central & 438 878.0 238.3 92.9 1429.0
South Wales
a
East Anglia 454 736.7 234.6 0 1296.8
South Midlands 543 748.8 228.1 0 1797.4
South-east 373 742.7 230.4 0 1455.2
Scotland 720 862.5 224.6 0 1872.4
Deprivation score
1 Most afﬂuent 883 819.2 232.1 0 1872.4
2 915 813.3 249.1 0 1566.9
3 875 828.4 252.5 0 1797.4
4 796 832.7 250.2 0 1470.5
5 625 876.1 258.0 0 2027.2
6 542 873.2 254.3 0 1592.9
7 Most deprived 450 908.8 244.1 141.2 1796.3
aCentral and South Wales were combined for the purposes of this study.
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value of the distribution.
Cosmic ray dose rates increase systematically with increasing
altitude. However, most of the population live at relatively low alti-
tudes (see below), so it is reasonable to assume the variation in
dose rates seen in the analysis is mostly due to terrestrial gamma
rays.
The geographical trends in gamma-ray dose rate results by
Region that might be expected from knowledge of geological varia-
tions are obscured by variation in population density. For example:
studies of Wrixon et al (1988) have shown that the environmen-
tally based geographical weighted (outdoor) gamma ray dose
rates for Devon and Cornwall are the highest in the UK. However
the population weighted (indoor) gamma value for Devon is
around the median for county values in the UK. This is because
most of the population live in cities and towns such as Plymouth,
Exeter and Torbay which are not particularly high gamma ray
areas – the population of Dartmoor, a high gamma ray area, is
quite low. This is compounded by the grouping into health
regions – the Southwest grouping includes, for example, Hamp-
shire with some 600000 homes, whilst Cornwall has only
170000 homes. If data from Wrixon et al (1988) on indoor gamma
dose rates are amalgamated (as in the present study), a similar
ranking would be achieved.
Terrestrial gamma rays have been estimated to contribute about
30% of the total natural annual low-LET dose to bone marrow,
most of the remainder being due to cosmic rays (*40%) and
natural internal radio nuclides with the body (*30%) (Simmonds
et al, 1995). If 20% of young persons’ leukaemias are related to
natural low-LET radiation, as has been suggested from standard
radiological risk estimates for ages 0–24 (Simmonds et al, 1995;
COMARE, 1996), then about 6% of these leukaemias may be attri-
butable to terrestrial gamma rays. It is unlikely that a relative risk
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Table 3 Logistic regression modelling of absorbed dose rate in all diagnostic groups
Number Matched Unmatched
Variable Level Case Controls OR 95% CI OR 95% CI
Dose rate (mGy y
71) 5650.3 418 742 1–1–
Unadjusted for 650.3–5798.5 436 724 1.09 0.90–1.34 1.06 0.90–1.26
deprivation 798.5–5916.2 459 702 1.17 0.95–1.43 1.16 0.98–1.37
916.2–51045.3 423 737 1.04 0.84–1.29 1.02 0.86–1.20
4=1045.3 429 732 1.00 0.80–1.25 1.04 0.88–1.23
Dose rate (mGy y
71) 5650.3 418 742 1–1–
Adjusted for 650.3–5798.5 436 724 1.10 0.90–1.35 1.06 0.89–1.25
deprivation 798.5–5916.2 459 702 1.17 0.95–1.44 1.15 0.97–1.36
916.2–51045.3 423 737 1.04 0.84–1.29 1.00 0.84–1.18
4=1045.3 429 732 0.97 0.78–1.21 1.00 0.84–1.19
Table 4 Conditional logistic regression modelling of dose rate (mGy y
71) without and with adjustment for deprivation for speciﬁc diagnostic groups
OR (95% CI) for each diagnostic group
Other Other solid
Dose rate (m mGy y
71) ALL leukaemias NHL HD CNS tumours
Unadjusted
5650.3 1 (7)1 ( 7)1 ( 7)1 ( 7)1 ( 7)1 ( 7)
650.3–5798.5 1.00 (0.72–1.40) 1.05 (0.45–2.42) 1.70 (0.79–3.67) 0.92 (0.26–3.28) 0.88 (0.53–1.44) 1.29 (0.90–1.86)
798.5–5916.2 1.20 (0.85–1.68) 1.26 (0.57–2.79) 1.31 (0.62–2.74) 1.23 (0.32–4.79) 1.01 (0.63–1.63) 1.22 (0.83–1.79)
916.2–51045.3 0.96 (0.67–1.37) 0.74 (0.32–1.75) 0.86 (0.38–1.95) 1.09 (0.25–4.78) 1.33 (0.80–2.22) 1.11 (0.76–1.63)
4=1045.3 0.93 (0.65–1.33) 0.97 (0.40–2.34) 0.65 (0.26–1.61) 0.87 (0.22–3.51) 1.33 (0.77–2.28) 1.01 (0.66–1.54)
Adjusted for deprivation
5650.3 1 (7)1 ( 7)1 ( 7)1 ( 7)1 ( 7)1 ( 7)
650.3–5798.5 1.03 (0.74–1.45) 0.87 (0.36–2.11) 1.63 (0.74–3.56) 0.99 (0.24–4.12) 0.93 (0.56–1.55) 1.28 (0.89–1.85)
798.5–5916.2 1.21 (0.86–1.70) 1.18 (0.52–2.72) 1.23 (0.57–2.64) 1.24 (0.26–5.84) 1.03 (0.64–1.66) 1.20 (0.81–1.78)
916.2–41045.3 0.97 (0.68–1.39) 0.66 (0.27–1.60) 0.83 (0.36–1.90) 1.05 (0.20–5.51) 1.33 (0.80–2.23) 1.12 (0.76–1.65)
4=1045.3 0.95 (0.66–1.37) 0.68 (0.26–1.82) 0.69 (0.27–1.76) 0.78 (0.17–3.64) 1.30 (0.75–2.24) 0.96 (0.62–1.47)
Test for trend in adjusted data (2 sided)
w
2 (P value)
1 0.11 (0.74) 0.62 (0.43) 1.10 (0.29) 0.25 (0.62) 2.04 (0.15) 0.25 (0.62)
1All have 1 degree of freedom.
Table 5 Odds ratio of household radon and TLD results – Tertile
distribution of TLD v levels of radon, both unadjusted and adjusted for de-
privation
Radon levels TLD tertiles: case numbers in brackets
(Bq m
73) 5758* 758–957* 4957*
0–24 unadjusted 1.0 (550) 1.1 (570) 1.0 (543)
adjusted 1.0 1.1 1.0
25–49 unadjusted 0.8 (107) 0.8 (116) 0.7{ (107)
adjusted 0.8 0.8 0.7{
50–99 unadjusted 0.6{ (40) 1.0 (44) 0.6{ (48)
adjusted 0.6{ 1.0 0.6
100–199 unadjusted 0.5 (11) 0.3 (5) 0.5 (10)
adjusted 0.5 0.3 0.5
200+ unadjusted 0.7 (2) 0.3 (3) 1.3 (8)
adjusted 0.7 0.3 1.4
*Gamma dose rate in mGy y
71. {Results statistically signiﬁcant results in P50.05.
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statistical power, modest variations in dose rate and limitations of
data collection are taken into account. Thus, the results of the
study are reassuring, in that they do not indicate any measurable
risk from natural gamma rays in the UK. Nevertheless, they do
not contradict expectations of a small risk based on standard meth-
ods of risk assessment.
The results do not indicate either a positive or negative trend
between gamma ray exposure and childhood cancer, the only
exception being CNS tumours which show a weak (statistically
not signiﬁcant) positive trend. That one such trend should be
observed when six groups are examined is hardly surprising. When
the estimated mean cosmic ray dose rate is taken into account, the
mean household terrestrial gamma-ray dose rate of 62.1 nGy h
71
is very similar to that found in the NRPB material (Wrixon et
al, 1988) of 60.1 nGy h
71.
The increase in measured household exposure with increase in
the deprivation index necessitated adjustment for socio-economic
factors, but this makes no signiﬁcant difference to the results. With
the exception of the highest measured gamma-ray dose rate and
radon concentration there was no evidence of any association
between the gamma-ray and the results of the radon analysis.
The number of households for which the highest levels of both
were recorded (8) was, however, very small.
In conclusion, in line with standard risk estimates, the ﬁndings
from this study are broadly reassuring.
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